Scientists at Kyoto University have used a reengineered spider venom peptide to deliver biomacromolecules into a cell

Chemists from Italy and Canada specializing in nanotechnology create a molecular slingshot that could shoot drugs at precise locations in the human body once triggered by specific disease markers

New technique reveals synaptic contributions to Parkinson's Disease

Implant could offer long-acting, removable form of prevention not currently available

After conducting a series of experiments, scientists found that it may be possible to boost the efficacy of medicine entering target cells via a nanoparticle

Technique could accelerate the development and use of gene therapies for such killers as heart disease, cancer, and Parkinson’s disease

The collaboration will enable the Center for Structured Organic Particulate Systems (C-SOPS) to study new methods for continuous manufacturing.

Drugs delivered during their molecular target’s daily downtime often do more harm than good, which is why biologists have struggled to pinpoint the precise timing of these molecules’ delivery systems

"What developers need is a safe way of predicting what would happen in a patient's body."

One of the biggest challenges in cancer therapy is being able to sufficiently deliver chemotherapy drugs to tumors without exposing healthy tissues to their toxic effects